TherapeuticsMD TXMD Balance Sheet (2010-2026)

NASDAQ TXMD
$2.19 +0.01 (+0.46%)
At close: Sep 18, 2026 · 4:00 PM EDT
Reported Financials

TherapeuticsMD Quarterly Balance Sheet

Periods 62 quarters
Latest Jun 2026

TherapeuticsMD reported total assets of $37.53M and total liabilities of $10.40M for the quarter ended Jun 2026, down 2.5% year over year. This balance sheet covers 62 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
104.84M64.91M30.38M37.55M38.33M49.32M17.25M13.73M10.17M4.33M4.34M5.23M5.05M5.06M5.75M6.07M7.12M7.48M8.42M9.19M
Short-term InvestmentsInvestments (Current)
11.25M11.25M11.25M
Cash & Current Investments
104.84M64.91M30.38M48.80M49.58M60.57M17.25M13.73M10.17M4.33M4.34M5.23M5.05M5.06M5.75M6.07M7.12M7.48M8.42M9.19M
Receivables - NetNet Receivables
37.40M36.18M35.41M45.80M32.16M21.57M19.57M17.24M
Receivables - OtherOther Receivables
3.09M3.22M2.91M3.32M3.56M3.00M3.74M3.67M3.52M3.21M3.39M
Receivables
37.40M36.18M35.41M45.80M32.16M24.66M23.13M20.76M
Raw Materials
3.49M3.04M4.39M0.43M1.95M
Work In Process
0.69M1.64M1.23M1.68M0.22M
Finished Goods
3.19M2.94M3.34M4.03M4.54M
Inventory
7.36M7.62M8.97M6.15M6.70M
Prepaid Assets
10.37M5.86M9.66M9.10M10.29M6.03M5.45M5.04M4.57M4.04M3.87M3.68M3.78M3.64M3.77M3.65M3.72M3.44M3.63M3.54M
Current Assets
159.98M119.47M84.42M98.60M87.48M55.35M24.73M19.61M17.44M11.80M11.52M11.82M12.15M12.26M12.51M13.46M14.50M14.45M15.26M16.12M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
1.39M0.82M1.08M0.71M0.55M0.08M0.06M0.04M0.02M
Intangibles
46.67M8.19M48.36M48.42M48.45M8.54M6.88M6.77M6.66M7.97M7.97M6.39M6.38M6.38M6.29M6.29M6.26M6.18M6.18M6.17M
Goodwill & Intangibles
46.67M8.19M48.36M48.42M48.45M8.54M6.88M6.77M6.66M7.97M7.97M6.39M6.38M6.38M6.29M6.29M6.26M6.18M6.18M6.17M
Long-Term Deferred Tax
176.63M158.04M167.37M
Other Non-Current Assets
0.25M48.70M0.25M0.25M0.25M0.25M0.25M0.25M0.25M0.34M0.09M0.06M0.06M0.13M0.21M0.43M0.47M0.44M0.42M0.40M
Non-Current Assets
49.65M50.00M48.96M47.60M46.43M35.11M34.87M34.08M33.05M31.51M30.57M28.30M27.40M26.56M25.72M25.04M24.17M23.21M22.32M21.41M
Assets
209.63M169.47M133.38M146.20M133.91M90.46M59.60M53.69M50.49M43.31M42.09M40.13M39.55M38.82M38.24M38.50M38.67M37.66M37.58M37.53M
Liabilities
Current Liabilities
Accounts Payables
19.59M3.37M20.75M13.98M13.38M2.16M2.33M1.51M0.70M0.03M0.14M0.14M0.23M0.26M0.18M0.35M0.26M0.38M0.01M0.46M
Notes Payables
1.75M
Dividends payables
Payables
19.59M3.37M20.75M13.98M15.13M2.16M2.33M1.51M0.70M0.03M0.14M0.14M0.23M0.26M0.18M0.35M0.26M0.38M0.01M0.46M
Accumulated Expenses
51.67M44.30M18.85M3.13M2.72M2.68M2.82M2.13M1.78M1.59M2.02M1.74M2.23M1.88M
Other Accumulated Expenses
13.34M41.23M59.23M43.57M18.85M14.36M11.48M6.93M0.41M0.09M0.25M0.20M0.30M
Short term Debt
15.00M188.27M202.86M90.78M93.60M
Current Leases
Current Deferred Revenue
Total Current Liabilities
86.27M252.89M264.83M163.99M174.07M46.84M19.34M14.36M14.51M6.85M6.47M5.82M5.98M5.17M4.74M4.66M4.95M4.79M4.91M5.00M
Non-Current Liabilities
Non-Current Debt
171.74M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
47.91M25.83M2.65M1.37M6.89M3.69M6.32M6.00M2.92M2.78M2.79M2.72M2.67M2.67M2.67M2.67M
Operating Leases
8.23M8.06M7.90M7.73M7.55M7.37M7.13M6.94M6.74M8.01M5.78M7.17M5.96M5.72M5.41M5.12M4.82M4.52M
Other Non-Current Liabilities
0.76M2.14M1.23M0.55M0.55M1.11M1.11M1.19M1.19M0.64M0.64M0.64M0.70M0.74M0.80M0.83M0.87M0.87M0.87M0.87M
Total Non-Current Liabilities
266.23M260.95M272.73M171.71M181.62M54.21M26.47M21.30M21.25M13.39M12.79M11.82M11.75M10.71M10.70M10.38M10.36M9.91M9.73M9.52M
Total Liabilities
266.99M263.09M273.96M172.27M182.18M55.31M27.58M22.49M22.44M14.02M13.42M12.46M12.46M11.45M11.50M11.21M11.23M10.78M10.61M10.40M
Shareholder's Equity
Total Debt
186.74M188.27M202.86M90.78M95.35M
Common Equity
-57.36M-93.62M-140.58M-26.07M-48.27M35.14M32.02M32.00M28.05M29.29M28.66M27.67M27.09M27.37M26.74M27.29M27.44M26.88M26.97M27.13M
Liabilities and Shareholders Equity
209.63M169.47M133.38M146.20M133.91M90.46M59.60M53.69M50.49M43.31M42.09M40.13M39.55M38.82M38.24M38.50M38.67M37.66M37.58M37.53M
Retained Earnings
-1008.40M-1051.36M-1100.38M-988.10M-1017.07M974.50M-942.97M-945.38M-948.76M-949.64M979.03M979.12M979.16M-951.82M-952.48M-951.92M-951.77M-952.39M-952.30M-952.14M
Preferred Shares